Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5841510 | Life Sciences | 2016 | 6 Pages |
Abstract
Our results suggest Olmesartan improves heart remodeling and function induced by pressure overload. P38MAPK inactivation attenuated by olmesartan via inhibition of TAK1 pathway plays an important role in the process.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lianpin Wu, Liqin Mei, Lin Chong, Yinqing Huang, Yuechun Li, Maoping Chu, Xiangjun Yang,